<status value="active"/> <experimental value="false"/> <date value="2026-03-17T21:02:03.8104715+00:00"/> <publisher value="FHIR Infrastructure"/> <contact> <name value="FHIR Infrastructure"/> <telecom> <system value="url"/> <value value="http://www.hl7.org/Special/committees/fiwg"/> </telecom> </contact> <description value="This cross-version ValueSet represents content from `http://terminology.hl7.org/ValueSet/v3-SubstanceAdminSubstitutionNotAllowedReason|2.0.0` for use in FHIR R4."/> <jurisdiction> <coding> <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/> <code value="001"/> <display value="World"/> </coding> </jurisdiction> <purpose value="This value set is part of the cross-version definitions generated to enable use of the value set `http://terminology.hl7.org/ValueSet/v3-SubstanceAdminSubstitutionNotAllowedReason|2.0.0` as defined in FHIR R5 in FHIR R4. The source value set is bound to the following FHIR R5 elements: * Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: FHIR ValueSet `http://terminology.hl7.org/ValueSet/v3-SubstanceAdminSubstitutionNotAllowedReason|2.0.0`, defined in FHIR R5 does not have any mapping to FHIR R4"/> <compose> <include> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <version value="2.1.0"/> <concept> <code value="ALGINT"/> <display value="allergy intolerance"/> </concept> <concept> <code value="COMPCON"/> <display value="compliance concern"/> </concept> <concept> <code value="PAT"/> <display value="Patient request"/> </concept> <concept> <code value="THERCHAR"/> <display value="therapeutic characteristics"/> </concept> <concept> <code value="TRIAL"/> <display value="clinical trial drug"/> </concept> <concept> <code value="_SubstanceAdminSubstitutionNotAllowedReason"/> <display value="SubstanceAdminSubstitutionNotAllowedReason"/> </concept> </include> </compose> <expansion> <timestamp value="2026-03-17T21:02:03.8104715+00:00"/> <contains> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <version value="2.1.0"/> <code value="ALGINT"/> <display value="allergy intolerance"/> </contains> <contains> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <version value="2.1.0"/> <code value="COMPCON"/> <display value="compliance concern"/> </contains> <contains> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <version value="2.1.0"/> <code value="PAT"/> <display value="Patient request"/> </contains> <contains> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <version value="2.1.0"/> <code value="THERCHAR"/> <display value="therapeutic characteristics"/> </contains> <contains> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <version value="2.1.0"/> <code value="TRIAL"/> <display value="clinical trial drug"/> </contains> <contains> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <version value="2.1.0"/> <code value="_SubstanceAdminSubstitutionNotAllowedReason"/> <display value="SubstanceAdminSubstitutionNotAllowedReason"/> </contains> </expansion> </ValueSet>

Generated Narrative: ValueSet R5-v3-SubstanceAdminSubstitutionNotAllowedReason-for-R4

This value set expansion contains 6 concepts.

System	Version	Code	Display	Definition
`http://terminology.hl7.org/CodeSystem/v3-ActReason`	2.1.0	ALGINT	allergy intolerance	Definition: Patient has had a prior allergic intolerance response to alternate product or one of its components.
`http://terminology.hl7.org/CodeSystem/v3-ActReason`	2.1.0	COMPCON	compliance concern	Definition: Patient has compliance issues with medication such as differing appearance, flavor, size, shape or consistency.
`http://terminology.hl7.org/CodeSystem/v3-ActReason`	2.1.0	PAT	Patient request	The Patient requested the action
`http://terminology.hl7.org/CodeSystem/v3-ActReason`	2.1.0	THERCHAR	therapeutic characteristics	The prescribed product has specific clinical release or other therapeutic characteristics not shared by other substitutable medications.
`http://terminology.hl7.org/CodeSystem/v3-ActReason`	2.1.0	TRIAL	clinical trial drug	Definition: The specific manufactured drug is part of a clinical trial.
`http://terminology.hl7.org/CodeSystem/v3-ActReason`	2.1.0	_SubstanceAdminSubstitutionNotAllowedReason	SubstanceAdminSubstitutionNotAllowedReason	Reasons why substitution of a substance administration request is not permitted.